Amikacin is commonly prescribed to pediatric patients as a bactericidal antibiotic. However,
limited scientific data is available to determine safe and toxic levels in this population. This …

Amikacin, an aminoglycoside, is used against Gram–ive and Gram+ ive microorganisms for
treating Sepsis, Meningitis, Jaundice neonatum, Respiratory diseases and Urinary Tract …

Objective: To conduct the pharmacovigilance study on the increased use of antibiotics in
pediatric treatment. Materials and Methods: A suitable, simple questionnaire associated with …

Methods This was a record-based study conducted by the department of pharmacology in
collaboration with the department of pediatrics. Detailed information regarding all ADR …

Objective: To conduct the pharmacovigilance study on the increased use of antibiotics in
pediatric treatment. Materials and Methods: A suitable, simple questionnaire associated with …

Introduction: Pharmacosurveillance during the administration of antibiotics is of extreme
importance in paediatric patients given their different physiology and adverse drug reaction …

OBJECTIVE: The objective of this study is to determine the nature and severity of adverse
drug reactions (ADRs) in pediatric patients. MATERIALS AND METHODS: In this …

Abstract Adverse Drug Reactions (ADRs) are an important cause of mortality and morbidity
and constitute an enormous burden on the society. Many studies have implicated that the …

The lack of adequate clinical trials in paediatrics has generated many issues in medicine
use for hospitalised children, such as the prescription of off-label or unlicensed drugs, the …

Body weight, age, and kidney function especially in neonates, significantly influence
amikacin distribution and/or clearance, causing large pharmacokinetics variability, which …